[{"AccountsPayableCurrent_0_Q1_USD":288257.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"Cash_0_Q1_USD":1507436.0,"IncreaseDecreaseInPrepaidExpense_1_Q1_USD":57933.0,"PrepaidExpenseCurrent_0_Q1_USD":292933.0,"ProceedsFromIssuanceOfPrivatePlacement_1_Q1_USD":5600000.0,"AdjustmentsToAdditionalPaidInCapitalWarrantIssued_1_Q1_USD":5600000.0,"SharePrice_0_Q1_USD":10.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":230000000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-1500.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"RepaymentsOfRelatedPartyDebt_1_Q1_USD":200000.0,"InvestmentIncomeInterest_0_Q1_USD":43000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":1507436.0,"ProceedsFromIssuanceInitialPublicOffering_1_Q1_USD":230000000.0,"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1_Q1_USD":10425486.0,"AssetsHeldInTrustNoncurrent_0_Q1_USD":230042685.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":1482436.0,"PaymentsOfStockIssuanceCosts_1_Q1_USD":4088814.0,"SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares_0_Q1_shares":22015212.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q1_USD":220152120.0,"InvestmentIncomeInterest_1_Q1_USD":42685.0,"UnrecognizedTaxBenefits_0_Q1_USD":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":1000000.0,"OperatingIncomeLoss_1_Q1_USD":-87774.0,"AdditionalPaidInCapital_0_Q1_USD":5046721.0,"Assets_0_Q1_USD":231843054.0,"AssetsCurrent_0_Q1_USD":1800369.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":1500000.0,"CommonStockSharesOutstanding_0_Q1_shares":5750000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":38074.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":51707.0,"Liabilities_0_Q1_USD":6690929.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":231843054.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"LiabilitiesCurrent_0_Q1_USD":390929.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-230000000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-28750.0,"NetIncomeLoss_1_Q1_USD":-45089.0,"ProceedsFromRelatedPartyDebt_1_Q1_USD":200000.0,"ProfitLoss_1_Q1_USD":-45089.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-47389.0,"StockholdersEquity_0_Q1_USD":5000005.0,"AccruedLiabilitiesCurrent_0_Q1_USD":35122.0,"DeferredTaxAssetsNet_0_Q1_USD":300.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":231511186.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_Q1_USD":0.0,"Ticker":"TOI","CIK":"1799191","name":"DFP HEALTHCARE ACQUISITIONS CORP.","OfficialName":"The Oncology Institute Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"520068227.0","Country":"United States","Sector":"Health Care","Industry":"Medical Specialities","Market":"NASDAQ","SP500":"nan","filed":"20200508"}]